{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:41:13Z","timestamp":1792132873715,"version":"4.4.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T00:00:00Z","timestamp":1508457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Astra Zeneca Germany"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0186043","type":"journal-article","created":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T13:34:31Z","timestamp":1508506471000},"page":"e0186043","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":127,"title":["Prevalence of deleterious germline variants in risk genes including BRCA1\/2 in consecutive ovarian cancer patients (AGO-TR-1)"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9663-5005","authenticated-orcid":true,"given":"Philipp","family":"Harter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hauke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Heitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Reuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kommoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Marm\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Heimbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Prieske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Richters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Burges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Neidhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"de Gregorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"El-Balat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Hilpert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Kimmig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Kast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jackisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjoung-Won","family":"Park-Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Hanker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Kr\u00f6ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus","family":"Pfisterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidrun","family":"Gevensleben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schnelzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimo","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Neunh\u00f6ffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Krockenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Y.","family":"Brucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"N\u00fcrnberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Altm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefin","family":"Lamla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Elser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"du Bois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hahnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Schmutzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,10,20]]},"reference":[{"key":"ref1","article-title":"Survival of women with cancers of breast and genital organs in Europe 1999\u20132007: results of the EUROCARE-5 study","author":"M Sant","year":"2015","journal-title":"Eur J Cancer"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3322\/caac.21349","article-title":"Cancer statistics, 2016","volume":"66","author":"RL Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"17","key":"ref3","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/jnci\/djg036","article-title":"A randomized clinical trial of cisplatin\/paclitaxel versus carboplatin\/paclitaxel as first-line treatment of ovarian cancer","volume":"95","author":"A du Bois","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s12325-012-0041-9","article-title":"Bevacizumab in the treatment of ovarian cancer","volume":"29","author":"F Heitz","year":"2012","journal-title":"Adv Ther"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1093\/annonc\/mds203","article-title":"The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane\/platinum-based therapy","volume":"23","author":"LC Hanker","year":"2012","journal-title":"Ann Oncol"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ygyno.2011.02.014","article-title":"Impact of a structured quality management program on surgical outcome in primary advanced ovrian cancer","volume":"121","author":"P Harter","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","article-title":"Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial","volume":"13","author":"P Harter","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"16","key":"ref8","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJM199704173361602","article-title":"Contribution of BRCA 1 mutations to ovarian cancer","volume":"336","author":"JF Stratton","year":"1997","journal-title":"N Engl J Med"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"HA Risch","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"A Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"5645","key":"ref11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"MC King","year":"2003","journal-title":"Science"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/sj.bjc.6604305","article-title":"The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions","volume":"98","author":"AC Antoniou","year":"2008","journal-title":"Br J Cancer"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE","volume":"105","author":"N Mavaddat","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"22","key":"ref14","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovaran (PLCO) Cancer Screening Randomized Controlled Trial","volume":"305","author":"SS Buys","year":"2011","journal-title":"JAMA"},{"issue":"5","key":"ref15","first-page":"1511","article-title":"Ovarian tumorgenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"leM Shih","year":"2004","journal-title":"Am J Pathol"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/IGC.0000000000000920","article-title":"Serous Tubal Intraepithelial Cacrinoma Associated With Extraovarian Metastases","volume":"27","author":"S Schneider","year":"2017","journal-title":"Int J Geynecol Cancer"},{"key":"ref17","article-title":"Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1or 2 mutation","author":"D M\u00fcller","year":"2017","journal-title":"Eur J Health Econ"},{"issue":"23","key":"ref18","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk","volume":"372","author":"DF Easton","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ygyno.2015.02.017","article-title":"Two decades beyond BRCA1\/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy","volume":"137","author":"CS Walsh","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ng.569","article-title":"Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene","volume":"42","author":"A Meindl","year":"2010","journal-title":"Nat Genet"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv214","article-title":"Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer","volume":"107","author":"SJ Ramus","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"42","key":"ref22","doi-asserted-by":"crossref","first-page":"15172","DOI":"10.1073\/pnas.1407909111","article-title":"Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer","volume":"111","author":"JI Kiiski","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"ref23","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk","volume":"372","author":"DF Easton","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ygyno.2015.02.017","article-title":"Two decades beyond BRCA1\/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy","volume":"137","author":"CS Walsh","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ng.569","article-title":"Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene","volume":"42","author":"A Meindl","year":"2010","journal-title":"Nat Genet"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv214","article-title":"Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer","volume":"107","author":"SJ Ramus","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"42","key":"ref27","doi-asserted-by":"crossref","first-page":"15172","DOI":"10.1073\/pnas.1407909111","article-title":"Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer","volume":"111","author":"JI Kiiski","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in woman with ovarian carcinoma","volume":"2","author":"BM Norquist","year":"2016","journal-title":"JAMA Oncol"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-13-2287","article-title":"Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas","volume":"20","author":"KP Pennington","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/humu.20880","article-title":"Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results","volume":"29","author":"SE Plon","year":"2008","journal-title":"Hum Mutat"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1186\/s12885-016-2966-x","article-title":"Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil","volume":"16","author":"S Maistro","year":"2016","journal-title":"BMC Cancer"},{"issue":"11","key":"ref32","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1158\/2159-8290.CD-15-0714","article-title":"Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer","volume":"5","author":"PA Konstantinopoulos","year":"2015","journal-title":"Cancer Discov"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12325-016-0281-1","article-title":"Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review","volume":"33","author":"DM Eccles","year":"2016","journal-title":"Adv Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"T Walsh","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1158\/1078-0432.CCR-07-4806","article-title":"BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark","volume":"14","author":"M Soegaard","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejca.2003.09.016","article-title":"One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden","volume":"40","author":"S Malander","year":"2004","journal-title":"Eur J Cancer"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group","volume":"30","author":"K Alsop","year":"2012","journal-title":"J Clin Oncol"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ygyno.2015.12.027","article-title":"BRCA1\/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study","volume":"140","author":"P Harter","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"8","key":"ref39","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/bjc.2016.273","article-title":"Ovarian carcinoma diagnosis: the clinical impact of 15 years of change","volume":"115","author":"S Kommoss","year":"2016","journal-title":"Br J Cancer"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Scambia G, Chalas E, Huang G, Grana Suarez B, Gonz\u00e1lez-Santiago S, Colombo N, et al. A novel oncologist-lead BRCA1\/2 germline mutation (gBRCAm) testing and counselling model for patients with ovarian cancer: Interim results from the ENGAGE (NCT02406235) study. Presented at Annual Meeting of the European Society of Medical Oncologist 2016 # LBA34.","DOI":"10.1093\/annonc\/mdw435.28"},{"key":"ref41","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN). Management of epithelial ovarian cancer. Edinburgh: SIGN; 2013 (SIGN publication no. 135). [November 2013]"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0186043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T19:51:25Z","timestamp":1570218685000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0186043"}},"subtitle":[],"editor":[{"given":"Alvaro","family":"Galli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,20]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0186043","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,20]]}}}